Document is current
Any future updates will be listed below
-
Authors
Chen, Jing
Ji, Dong
Jia, Jidong
Zhuang, Hui
Zhang, Xinxin
Wang, Fu-Sheng
Zhang, Wenhong
Dou, Xiaoguang
Tanwandee, Tawesak
Sarin, Shiv Kumar
Maiwall, Rakhi
Kumar, Manoj
Goh, George Boon-Bee
Ghazinyan, Hasmik
Chutaputti, Anuchit
Chen, Pei-Jer
You, Hong
Yu, Ming-Lung
George, Jacob
Omata, Masao
Wang, Gui-qiang
Lau, George https://orcid.org/0000-0002-8928-3769
,
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 8 March 2025
First Online: 18 June 2025
Declarations
:
: JC, DJ, HZ, FW, XD, TT, SS, RM, MK, GG, HG, AC, PC, HY, MO, GW have nothing to disclose. JJ declares consultation and speaker for BMS, Gilead and GSK. XZ declares funding from the Science and Technology Commission Shanghai Municipality. WZ declares funding from the National Natural Science Foundation of China. YL declares research support from Research Grant KMHK-DK(C)111004 and KMUH-DK(A)113002; research support from Abbvie, BMS, Gilead, Merck and Roche diagnostics; Consultant of Abbott, Abbvie, BMS, Gilead, Roche and Roche diagnostics; Speaker of Abbvie, BMS, Eisai, Gilead, Roche and Roche diagnostics. JG declares research support by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney; a National Health and Medical Research Council of Australia (NHMRC) Program Grant (APP1053206), Investigator and MRFF grants (APP2032407; NCRI000183; APP2016215; APP 2010795; APP1196492) and a Cancer Institute, NSW grant (2021/ATRG2028). GL declares consultation for AstraZeneca.
: We used only published data, so approval from an ethics committee was not required.
